Great Lakes Advisors’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-106,662
Closed -$5.75M 614
2017
Q4
$5.75M Buy
106,662
+11,356
+12% +$621K 0.13% 150
2017
Q3
$5.44M Buy
+95,306
New +$5.58M 0.13% 147

Other funds holding BIVV

Great Lakes Advisors's BIVV Position: Q1 2018 in Review

Great Lakes Advisors sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 106,662 shares — an estimated $5.75M sold.

Great Lakes Advisors first reported a position in BIVV in Q3 2017 and held it in 2 quarters. The position peaked at $5.75M in Q4 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Great Lakes Advisors reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Great Lakes Advisors sold 106,662 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $5.75M.
  • Great Lakes Advisors first reported a position in Bioverativ Inc. Common Stock in Q3 2017 and held it in 2 quarters.
  • Great Lakes Advisors's Bioverativ Inc. Common Stock position peaked at $5.75M in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Great Lakes Advisors's 13F filing for Q1 2018, filed 7 May 2018.